National Asthma and Allergy Awareness Month Empowers Individuals and Communities
30 avr. 2024 10h22 HE
|
Asthma and Allergy Foundation of America
Washington, DC, April 30, 2024 (GLOBE NEWSWIRE) -- Since 1984, the Asthma and Allergy Foundation of America (AAFA) has designated May as National Asthma and Allergy Awareness Month. This year, AAFA...
Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel
26 mars 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, March 26, 2024 (GLOBE NEWSWIRE) -- Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis,...
Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
12 mars 2024 11h01 HE
|
Intrommune Therapeutics
Intrommune Therapeutics today announced the appointment of Dr. Jonathan Rich to its board of directors and Hem Pandya as Executive Chairman of the board.
Latitude Food Allergy Care Announces the Opening of its New San Francisco Clinic; Pacific Heights Clinic is the First-of-its-Kind and Only Clinic in San Francisco Specifically Dedicated to Food Allergy Patients
06 mars 2024 09h57 HE
|
Latitude Food Allergy Care
San Francisco, CA, March 06, 2024 (GLOBE NEWSWIRE) -- Latitude Food Allergy Care, the leading network of clinics providing life-changing testing and treatment, including oral immunotherapy (OIT) and...
Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment
22 févr. 2024 09h34 HE
|
Intrommune Therapeutics
OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
16 févr. 2024 11h24 HE
|
F. Hoffmann-La Roche Ltd
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate...
AAFA Statement on Uber Eats Super Bowl Ad
08 févr. 2024 15h20 HE
|
Asthma and Allergy Foundation of America
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement which may be attributed to Kenneth Mendez, president and CEO: ...
Food Allergy Market to Witness Remarkable Growth, Key Insights, and Global Outlook Revealed in New 2031 Forecast Report
06 févr. 2024 10h06 HE
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
06 févr. 2024 09h34 HE
|
Intrommune Therapeutics
New study is the first to evaluate Oral Mucosal Immunotherapy (OMIT) for the treatment of food allergy
UPDATE Latitude Food Allergy Care Announces the Opening of its Second New York City Location; Brooklyn Heights Clinic Will Provide Exceptional Food Allergy Care
01 févr. 2024 10h01 HE
|
Latitude Food Allergy Care
Redwood City, CA and New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Latitude Food Allergy Care, the leading network of clinics providing life-changing testing and treatment, including oral...